Should PNPO Deficiency Be Treated In Utero? Clinical Findings From Prenatal Pyridoxine Therapy
Open Access
- 20 April 2026
- journal article
- Published by Wiley in JIMD Reports
- Vol. 67 (3)
Abstract
Pyridox(am)ine‐5′‐phosphate oxidase (PNPO) deficiency is characterized by early‐onset epileptic encephalopathy refractory to standard antiseizure medications. It is caused by variants in the PNPO gene, resulting in deficient PNPO enzyme activity, which normally converts pyridoxine‐5′‐phosphate and pyridoxamine‐5′‐phosphate (two vitamers of vitamin B6) into the active cofactor, pyridoxal‐5′‐phosphate (PLP). Treatment relies on PLP or pyridoxine in some cases. Long‐term outcomes remain suboptimal. We describe two cases of unrelated children treated with vitamin B6 (pyridoxine) in utero: one with a confirmed prenatal PNPO diagnosis and one at risk due to family history but ultimately unaffected. In utero pyridoxine, combined with early postnatal PLP treatment, allowed excellent seizure control and normal neurodevelopment in the long term. Notably, our first patient, treated from birth, is now 10 years old, representing the oldest reported PNPO‐deficient individual treated from birth. Case 2 highlights the safety of prenatal B6 supplementation even in unaffected fetuses. These observations support prenatal pyridoxine supplementation as a safe and potentially beneficial strategy in at‐risk PNPO pregnancies.Keywords
This publication has 15 references indexed in Scilit:
- ACOG Practice Bulletin No. 189: Nausea And Vomiting Of PregnancyObstetrics & Gynecology, 2018
- Normal Neurodevelopmental Outcomes in PNPO Deficiency: A Case Series and Literature Review2015
- PNPO Deficiency and Cirrhosis: Expanding the Clinical Phenotype?2015
- Pyridoxine (vitamin B6) supplementation during pregnancy or labour for maternal and neonatal outcomesCochrane Database of Systematic Reviews, 2015
- Cirrhosis Associated with Pyridoxal 5′-Phosphate Treatment of Pyridoxamine 5′-Phosphate Oxidase Deficiency2014
- Epilepsy due to PNPO mutations: genotype, environment and treatment affect presentation and outcomeBrain, 2014
- Interventions with Vitamins B6, B12 and C in PregnancyPaediatric and Perinatal Epidemiology, 2012
- Status epilepticus in a neonate treated with pyridoxine because of a familial recurrence risk for antiquitin deficiency: pyridoxine toxicity?Developmental Medicine & Child Neurology, 2011
- PNPO deficiency: An under diagnosed inborn error of pyridoxine metabolismMolecular Genetics and Metabolism, 2008
- B6‐responsive disorders: A model of vitamin dependencyJournal of Inherited Metabolic Disease, 2005